Cargando…
Hypermethylation of the HIC1 promoter and aberrant expression of HIC1/SIRT1 contribute to the development of thyroid papillary carcinoma
Hypermethylation leading to the loss of hypermethylated in cancer-1 (HIC1) gene expression occurs in many different types of human cancer. HIC1 is a transcriptional repressor that directly binds to the promoter region of NAD-dependent deacetylase sirtuin-1 (SIRT1). SIRT1 functions in cell growth, is...
Autores principales: | Wu, Wenyi, Zhang, Liting, Lin, Jianqing, Huang, Hanwei, Shi, Bai, Lin, Xingong, Huang, Zhongxin, Wang, Chaoyang, Qiu, Jianlong, Wei, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356670/ https://www.ncbi.nlm.nih.gov/pubmed/27793057 http://dx.doi.org/10.18632/oncotarget.12936 |
Ejemplares similares
-
Genomic deletion and promoter methylation status of Hypermethylated in Cancer 1 (HIC1) in mantle cell lymphoma
por: Stöcklein, Heike, et al.
Publicado: (2008) -
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer
por: Nicoll, G, et al.
Publicado: (2001) -
‘What puts the ‘Hic’ into Hiccups?’
por: Seifi, Ali, et al.
Publicado: (2022) -
Class II transactivator (CIITA) mediates transcriptional repression of pdk4 gene by interacting with hypermethylated in cancer 1 (HIC1)
por: Fang, Mingming, et al.
Publicado: (2015) -
HIC1 (Hypermethylated in Cancer 1) modulates the contractile activity of prostate stromal fibroblasts and directly regulates CXCL12 expression
por: Dubuissez, Marion, et al.
Publicado: (2020)